NCT05702827

Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 148 (actual)
• Sponsor: TriHealth Inc. · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will compare the use of a dual-agent local analgesic (bupivacaine-meloxicam) for abdominal incisions in patients undergoing retropubic mid-urethral sling surgery to see if narcotic usage and pain are impacted.

Conditions

• Stress Urinary Incontinence
• Surgical Incision
• Pain Vulva

Interventions

Type	Name	Description
DRUG	Bupivacaine-Meloxicam	All patients will receive standard of care but the study arm will also receive Bupivacaine-Meloxicam in addition.

Timeline

• Start date: 2023-01-23
• Primary completion: 2024-03-22
• Completion: 2024-04-18
• First posted: 2023-01-27
• Last updated: 2024-11-22

Locations

2 sites across 1 country: United States

Regulatory

• FDA-regulated drug study